After the first injection, you’ll likely feel a lot better going into future appointments (about every six weeks on average, says Dr. Murray) knowing what to expect.
And here’s another positive: The newest anti-VEGF drug, Beovu, was just approved by the FDA for use every three months (after three initial “loading” doses), and more options may be on the horizon, says Dr. Murray. Yes, that means fewer injections!
“[When I started practicing] in 1991, every person with wet macular degeneration was going to end up blind,” says Dr. Murray. “Now, 85% to 90% are going to keep or improve the vision that they start with. It’s a really exciting time.”